A case series and immunophenotypic analysis of CK20-/CK7+ primary neuroendocrine carcinoma of the skin

Journal of Cutaneous Pathology

Volumn 34, Issue 12, 2007, Pages 918-923

  Calder, Kenneth B ^a,d   Coplowitz, Shana ^a   Schlauder, Scott ^a   Morgan, Michael B ^a,b,c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Ameripath Labs   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 7; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; MERKEL CELL TUMOR; NEUROENDOCRINE DISEASE; SKIN CARCINOMA; SKIN DISEASE; TERTIARY HEALTH CARE;

AGED; CARCINOMA, MERKEL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KERATIN-20; KERATIN-7; MALE; MIDDLE AGED; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 36249020944     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2007.00759.x     Document Type: Article

References (33)

1. Schwartz RA, Lambert WC. The Merkel cell carcinoma: a 50-year retrospect. J Surg Oncol 2005 89 : 5.
2. Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. J Clin Oncol 2002 20 : 588.
3. Tang CK, Toker C. Trabecular carcinoma of the skin: an ultrastructural study. Cancer 1978 42 : 2311.
4. Veness MJ. Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma): an overview on management. Australas J Dermatol 2006 47 : 160.
5. Silva EG, Mackay B, Goepfert H, et al. Endocrine carcinoma of the skin (Merkel cell carcinoma). Pathol Annu 1984 19 : 1.
6. Tai PT, Yu E, Winquist E, et al. Chemotherapy in neuro-endocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. J Clin Oncol 2000 18 : 2493.
7. Poulsen M. Merkel-cell carcinoma of the skin. Lancet Oncol 2005 5 : 593.
8. Sidhu GS, Feinger H, Flotte TJ, et al. Merkel cell neoplasms. Am J Dermatopathol 1980 2 : 101.
9. Voog E, Biron P, Martin JP, et al. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Cancer 1999 85 : 2589.
10. Sibley RK, Dahl D. Primary neuroendocrine (Merkel cell?) carcinoma of the skin. II. An immunocytochemical study of 21 cases. Am J Surg Pathol 1985 9 : 109.
11. Fantini F, Johansson O. Neurochemical markers in human cutaneous Merkel cells. An immunohistochemical investigation. Exp Dermatol 1995 4 : 356.
12. Gould VE, Moll R, Moll I, et al. Biology of disease. Neuroendocrine (Merkel) cells of the skin: hyperplasias, dysplasias, and neoplasms. Lab Invest 1985 52 : 334.
13. Ortonne JP, Petchot-Bacque JP, Verrando P, et al. Normal Merkel cells express a synaptophysin-like immunoreactivity. Dermatologica 1988 177 : 1.
14. Moll I, Kuhn C, Moll R. Cytokeratin 20 is a general marker of cutaneous Merkel cells while certain neuronal proteins are absent. J Invest Dermatol 1995 104 : 910.
15. Jensen K, Kholer S, Rouse RV. Cytokeratin staining in Merkel cell carcinoma: an immunohistochemical study of Cytokeratins 5/6, 7, 17 and 20. Appl Immunohistochem Mol Morphol 2000 8 : 310.
16. Acebo E, Vidaurrazaga N, Varas C, et al. Merkel cell carcinoma: a clinicopathological study of 11 cases. J Eur Acad Dermatol Venereol 2005 5 : 546.
17. Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol 2003 49 : 832.
18. Hodgson NC. Merkel cell carcinoma: changing incidence trends. J Surg Oncol 2005 89 : 1.
19. Brady MS. Current management of patients with Merkel cell carcinoma. Dermatol Surg 2004 30 : 321.
20. Alam M. Management of Merkel cell carcinoma. Arch Dermatol 2006 142 : 771.
21. Hanly AJ, Elgart GW, Jorda M, et al. Analysis of thyroid transcription factor-1 and cytokeratin 20 separates Merkel cell carcinoma from small cell carcinoma of the lung. J Cutan Pathol 2000 27 : 118.
22. Folpe AL, Gown AM, Lamps LW, et al. Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors. Mod Pathol 1999 12 : 5.
23. Di Loreto C, Di Lauro V, Puglisi F, et al. Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma. J Clin Pathol 1997 50 : 30.
24. Di Loreto C, Puglisi F, Di Lauro V, Damante G. TTF-1 protein expression in pleural malignant mesothelioma and adenocarcinoma of the lung. Cancer Lett 1998 124 : 73.
25. Moll R, Franke WW. Cytoskeletal differences between human neuroendocrine tumors: a cytoskeletal protein of molecular weight 46,000 distinguishes cutaneous from pulmonary neuroendocrine neoplasms. Differentiation 1985 30 : 165.
26. Moll I, Lowe A, Jurgen L, et al. Cytokeratin 20 in human carcinomas. Am J Pathol 1992 140 : 427.
27. Bobos M, Hytiroglou P, Kostopoulos I, et al. Immunohistochemical distinction between Merkel cell carcinoma and small cell carcinoma of the lung. Am J Dermatopathol 2006 28 : 99.
28. Wang NP, Zee S, Zarbo RJ, et al. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 1995 3 : 99.
29. Blumenfeld W, Turi GK, Harrison G, et al. Utility of cytokeratin 7 and 20 subset analysis as an aid in the identification of primary site of origin of malignancy in cytologic specimens. Diagn Cytopathol 1999 20 : 63.
30. Toker C. Trabecular carcinoma of the skin. Am J Dermatopathol 1982 4 : 497.
31. Camisa C, Weissmann A. Friedrich Sigmund Merkel part II. The cell. Am J Dermatopathol 1982 4 : 527.
32. Brwon HA, Sawyer DM, Woo T. Intraepidermal Merkel cell carcinoma with no dermal involvement. Am J Dermatopathol 2000 22 : 65.
33. Yao DX, Hoda SA, Chiu A, et al. Intraepidermal cytokeratin 7 immunoreactive cells in the non-neoplastic nipple may represent interepithelial extension of lactiferous duct cells. Histopathology 2002 40 : 230.